Massachusetts General Hospital, MGH Banner Patient Care Services Address 55 Fruit Street Boston MA 02114
  Home > Nursing > Oncology > Outpatient Infusion > Outpatient Infusion, Cox 1
 
     
 

Nursing Director
Ellen M. Fitzgerald, RN, MSN

PROFILE
Bigelow 12 is a 15 bed/chair unit. There are 10 chairs and 5 beds. The hours of operation are Monday through Friday from 8 AM to 6:30 PM.

UNIT FOCUS
Adult cancer patients are referred to the Infusion Units from the oncology practices and the Bone Marrow Transplant program. Patients are referred for treatment with and management of toxicities from chemotherapy and biotherapy. Patients who are treated with chemotherapy and biotherapy for malignant disease are also referred to the Infusion Units for treatment related or supportive therapies such as blood products, hydration, antibiotic therapy, and pain management.

Operations Coordinator
Frank Powers, BA

Clinical Nurse Specialist

Common nursing problems are related to the primary disease and disease- or treatment-related symptoms, and include:

  • Protective mechanisms: Alterations in mobility, skin integrity (including GVHD), and neurologic status; and myelosuppression
  • GI and GU Function: Alterations in elimination and nutrition
  • Cardiopulmonary Function: Alterations in ventilation and circulation
  • Oncologic Emergencies: hypercalcemia, DIC, SIADH, sepsis, tumor lysis syndrome, hypersensitivity reactions, cord compression, ICP, cardiac tamponade, and SVC syndrome
  • Quality of Life: Sexuality, pain, fatigue, altered body image, coping.

Staff nurses support the organizational mission and the Cancer Center investment in clinical research. In tandem with the Cancer Center Protocol Office and the Research Nursing Director, staff nurses participate in the administration of all phases of clinical trials on which their primary patients may be enrolled. The Infusion Unit nurse is responsible for patient education, medication administration, symptom management, and documentation of toxicities for those patients participating in clinical trials as those patients receiving standard regimens.

Patients are followed throughout the entire trajectory of their illness: diagnosis and treatment, rehabilitation, long-term follow-up, and when necessary, palliative care. There is a strong commitment to primary nursing. Patients readily identify the nurse most involved in their care. However, all disciplines are involved in providing care and are as diverse as the range of needs patients express. These disciplines include social service, nutrition, psychiatry, palliative care service, pain service, occupational and physical therapy, and chaplaincy.

PATIENT CARE DELIVERY MODEL
Nurses are committed to primary nursing and work in a collaborative practice model with physicians and nurse practitioners, in the Division of Hematology-Oncology.

Nursing care is guided by institutional and national standards. These standards of care include those developed by the MGH Department of Nursing and the national standards of care developed by the Oncology Nursing Society with the American Nurses Association.

Nurses who are assigned to the Infusion Units will be certified in chemotherapy administration and blood product administration as described by the MGH Center for Clinical and Professional Development (CCPD).

TEAM MEMBERS
Registered nurses (RNs) who are certified in the administration of chemotherapy and blood products work in collaborative practice with oncologists and nurse practitioners. Critical Care Technicians (CCTs), directed by the RN, support the RN in delivering patient care. An Oncology Care Coordinator is available to assist the nursing/medical staff with planning patients' complex home care needs, including home IV therapy, prescription drug reimbursement, and facilitate referrals. Secretarial staff support the overall operations and scheduling.

Nursing Directors, a clinical nurse specialist and an operations coordinator make up the management triad. This team is responsible for establishing standards for care, initiating quality improvement projects, and setting/supporting the overall tone for patient care. To inquire about positions available on this unit, contact Jeff Hickey at jjhickey@partners.org.

SCHEDULING PRACTICES
The unit budget is prepared and negotiated annually prior to beginning of the fiscal year using current and historical data and trends in volume (workload) and resource utilization and in concert with unit, departmental, and hospital goals and projections (personnel budget, FTE budget). Performance against budget is reviewed and adjusted during the fiscal year as needed based on major changes in activity, resource requirements, goals, or projections.

STAFF ORIENTATION
Nurse orientation to the Infusion Units requires a minimum of six weeks. New nurse employees to the MGH will be required to attend Hospital New Employee Orientation, General Nursing Orientation through The Norman Knight Nursing Center for Clinical & Professional Development, and a unit-based orientation. Transfers from other nursing units within MGH where chemotherapy administration is included in the scope of practice will require orientation to the Infusion Units.

RNs are expected to have completed both Hospital Orientation and Nursing Orientation and the associated competencies before proceeding to Unit orientation. Successful completion of Unit-based orientation requires (but is not limited to) completion of chemotherapy, blood product, research, and ambulatory infusion competencies.

CCT Orientation requires a minimum of four weeks. CCTs are expected to have completed both Hospital Orientation and Nursing Orientation and the associated competencies before proceeding to Unit orientation.

Practice Assistant orientation requires a minimum of four weeks. Orientees are expected to have completed Hospital Orientation before completing the Unit orientation.

EDUCATIONAL AND DEVELOPMENT OPPORTUNITIES
Infusion Unit staff nurses support the organizational mission and the Cancer Center investment in clinical research. To that end, nurses are provided with education from the Research Nursing Director and designated clinical research nurses, which includes didactic information and clinical precepting. This is done on an individual basis because of the growth in the number and complexity of clinical trials, the evolving nature of experimental cancer therapies, and the Infusion Unit's commitment to disease-focused treatment teams. Thus, the disease-related collaborative practices develop proficiency in the trials associated with their clinical focus.